京津冀医药制造业产业协同的实证研究  

Empirical Study of the Industrial Cooperation of Pharmaceutical Enterprises in Beijing, Tianjin and Hebei Province

作　　者：张淑莲[1] 刘冬[1] 高素英[1] 刘建朝[1] 

机构地区：[1]河北工业大学管理学院,天津300130

出　　处：《河北经贸大学学报》2011年第5期87-92,共6页Journal of Hebei University of Economics and Business

基　　金：教育部人文社会科学研究基金资助项目(09YJA790058);天津市社科规划基金资助项目(TJYY08-1-037);河北省自然科学基金项目(G2009000137);河北省教育厅重点资助项目(NO.24;2009)

摘　　要：医药制造业作为京津冀重点发展的产业,如何形成京津冀具有竞争力的产业是个亟待解决的问题。通过运用灰色关联分析法研究京津冀医药制造业的协同问题得出结论为,北京和天津应该主要侧重于新医药产品以及设备的研发工作,河北主要是辅助二者;天津在主营业务收入方面与医药制造业的产值关联较大,所以天津应该在医药制造业产品的销售方面发挥较大作用;河北在固定资产的投资及新增固定资产方面占有比较优势,所以应该侧重于传统医药产品的制造方面以及医药设备的制造。Pharmacy is the key industry for Beijing, Tianjin and Hebei Province. How to make it a strongly competitive industry is an urgent task. This paper analyzes the cooperation of total industrial output, R ＆ D expenditure, average annual number of employees, investment in fixed assets, principal operation income in the pharmaceutical enterprises in Beijing, Tianjin and Hebei Province with gray correlation analysis in order to evaluate the development of these enterprises. The conclusion is Beijing and Tianjin shall focus on the research and development of new drugs and equipment while Hebei shall support their efforts; Tianjin shall play a big role in the selling of the pharmaceutical production facilities since its principal operation income mainly comes from the production facilities manufacturing; Hebei need to pay more attention to the making of tradition medical products and appliances as it has comparative advantages in the investment in fixed assets.

关 键 词：京津冀 医药制造业 产业协同 灰色关联分析 

分 类 号：F407[经济管理—产业经济]